Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI
Clinical trial NCT05845749 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05845749
- Sponsor
- University of California, San Francisco
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-25
- Primary completion
- 2028-12-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.